XML 127 R106.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL INFORMATION OF PARENT COMPANY - PARENT COMPANY CONDENSED STATEMENTS OF CASH FLOWS (Details)
 12 Months Ended
Dec. 31, 2022
CNY (¥)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
CNY (¥)
Dec. 31, 2020
CNY (¥)
Cash flows from operating activities:        
Net income (loss) ¥ (979,492,255) $ (142,013,027) ¥ (416,825,268) ¥ 393,433,738
Adjustments for:        
Share-based compensation expenses 202,345,626 29,337,358 150,166,481 55,056,426
Fair value change on warrants liability       (37,851)
Amortization of discount and interest on convertible notes 23,197,049 3,363,256 120,626,467 2,923,316
Foreign exchange (gain) loss 6,301,271 913,598 6,449,136 8,319,669
Cancellation of ordinary shares (1,876,314) (272,040)    
Consulting fees paid by issuance of shares       6,781,815
Gain from change in fair value of conversion feature derivative liability (37,249,976) (5,400,739) (62,246,860)  
Payment of issuance cost by issuance of shares (2,985,626) (432,875)   455,658
Changes in operating assets and liabilities:        
Change in prepayments and other current assets 72,383,805 10,494,665 (537,076,522) (2,877,084)
Change in accrued expenses and other current liabilities (71,722,378) (10,398,767) 60,345,979 (21,039,288)
Increase/(Decrease) in interest payable 1,192,955 172,962 937,328 (5,371,931)
Net cash (used in) provided by operating activities (154,700,000) (22,400,000) (687,688,577) (106,253,254)
Cash flows from investing activities:        
Net cash (used in) provided by investing activities (248,785,539) (36,070,512) (141,883,073) 438,263,208
Cash flows from financing activities:        
Proceeds from the issuance of ordinary shares and warrants     1,011,476,118 47,430,195
Proceeds from the issuance of convertible note 33,704,460 4,886,687 161,588,128 3,358,369
ADS issuance fee     (3,720,691) (7,849,390)
Net cash provided by (used in) financing activities 33,025,690 4,788,275 1,227,436,008 (310,686,195)
Effect of foreign exchange rate changes on cash and cash equivalents 144,985 21,020 (1,139,822) 259,337
Net change in cash and cash equivalents (370,357,040) (53,696,723) 396,724,536 21,583,096
Cash and cash equivalents, beginning of period 428,420,773      
Cash and cash equivalents, end of period 58,063,733 8,418,450 428,420,773  
Supplement disclosure of cash flow information:        
Interest paid       47,695,297
Parent Company        
Cash flows from operating activities:        
Net income (loss) (974,859,049) (141,341,276) (411,234,755) 397,883,388
Adjustments for:        
Share-based compensation expenses 0 0 0 55,056,426
Employee share-based compensation expense 202,345,626 29,337,358 150,166,481 0
Fair value change on warrants liability 0 0 0 (37,851)
Interest expenses 0 0 120,626,467 0
Amortization of discount and interest on convertible notes 23,074,518 3,345,491 0 2,923,316
Foreign exchange (gain) loss (166,222) (24,100) 4,465,094 (29,578,454)
Cancellation of ordinary shares (1,876,314) (272,040)    
Equity in loss (income) of subsidiaries and VIE 773,156,627 112,097,174 108,608,497 (410,073,394)
Consulting fees paid by issuance of shares 0 0 0 6,781,815
Gain from change in fair value of conversion feature derivative liability (37,249,976) (5,400,739) (62,246,860) 0
Gain on extinguishment of convertible notes 8,135,104 1,179,479 (2,296,722) (56,755,902)
Gain on waiver of interest-free loan 0 0 0 (34,881,000)
Payment of issuance cost by issuance of shares 0 0 0 455,658
Changes in operating assets and liabilities:        
Change in prepayments and other current assets 56,226 8,152 4,033,993 (4,026,346)
Change in amounts due from intercompany 49,338,235 7,153,372 (1,192,553,035) 349,361,587
Change in accrued expenses and other current liabilities (46,565,182) (6,751,317) 49,376,705 (566,162)
Increase/(Decrease) in interest payable 1,192,955 172,962 937,328 0
Net cash (used in) provided by operating activities (3,417,452) (495,484) (1,230,116,807) 276,543,081
Cash flows from investing activities:        
Purchase of property, plant and equipment (17,640,000) (2,557,560)    
Net cash (used in) provided by investing activities (17,640,000) (2,557,560)    
Cash flows from financing activities:        
Proceeds from the issuance of ordinary shares and warrants 0 0 64,471,143 47,430,195
Proceeds from the issuance of convertible note 33,704,460 4,886,687 161,588,128 3,358,369
Purchase of other investment 22,277,084 3,229,874    
ADS issuance fee 0 0 (3,720,691) 0
New issued stock to investors 0 0 1,011,476,118 0
Proceeds from disposal of other investment 15,228,067 2,207,862    
Repayments of convertible notes 0 0 0 (318,929,623)
Net cash provided by (used in) financing activities 26,655,443 3,864,675 1,233,814,698 (268,141,059)
Effect of foreign exchange rate changes on cash and cash equivalents 862,449 125,045 0 0
Net change in cash and cash equivalents 6,460,440 936,676 3,697,891 8,402,022
Cash and cash equivalents, beginning of period 12,243,809 1,775,185 8,545,918 143,896
Cash and cash equivalents, end of period 18,704,249 2,711,861 12,243,809 8,545,918
Supplement disclosure of cash flow information:        
Interest paid ¥ 0 $ 0 ¥ 0 ¥ 36,310,455